Are you interested in learning about the Food and Drug Administration’s drug approval process?  Do you want to better understand how to evaluate the results of clinical trials?

Breast Cancer Action advocates for more effective and less toxic breast cancer treatments by shifting the balance of power in the FDA’s drug approval process away from the powerful pharmaceutical industry.

Join us for the second of BCAction’s free monthly webinar series to find out how to help make sure that the FDA’s standards put public health before private profit. We will focus on how the competing interests of pharmaceutical companies and regulatory governmental bodies can fail to deliver safe and effective drugs that patients need.  If you sign up, you will learn about power players at the FDA, the origins of the accelerated approval process, and more.

Title: Patients Before Profits: What You Should Know About the FDA, Big Pharma, and Breast Cancer

Featuring: Miriam Hidalgo, BCAction Volunteer Program Coordinator

Jane Zones, Medical Sociologist and Former BCAction Board Member